Dear readers! We present to your attention the third issue of the LOGISTICS journal for 2025. Our editorial staff, like all our colleagues, is preparing for the TransRussia 2025 exhibition, the largest event in the industry. In this issue, we have prepared an interview with Natalia Lomunova, Director of TransRussia, with whom we are talking about a flexible approach, new participants and digital services. We continue the series of articles from P.V.
Dear readers! We present to your attention the first issue of the LOGISTICS journal in 2025. First of all, we would like to draw readers' attention to our new partner R1 Development, a development company that creates a new generation environment and specializes in the construction of industrial, logistics, commercial and residential real estate. One of the projects of R1 Development is the Druzhba industrial park network.
Dear readers! We present to your attention the final issue of the LOGISTICS journal in 2024. We have tried to make it rich and interesting. Today, many Russian companies operate under strict sanctions restrictions, which force them to reorient logistics flows. One of the possible solutions to this problem may be the Russia – Mongolia – China economic corridor. Details can be found in the article by Alexandra Kazunina.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
CV PROTEK became No.1 in the top pharmaceutical distributors list in 2017 according to the analytics company IQVIA.
In 2017 the company accounted for 18.4% share of the direct sales market, with 7.1% increase of direct sales.
Katren ranked second with 17.5% of market share and Pulse ranked third with 13.8%.
According to IQVIA, CV PROTEK keeps abreast of the market trends and due to measures taken by CV PROTEK to strengthen the company’s vertical, the company leads the top pharmaceutical distributors list.
Table 1 Rating of the largest distributors* in the market of direct sales of medicinal products (including preferential provision of medicines), 1-4 sq. 2017
|
Rank |
Distributor |
Market share of direct sales of medicinal products, % |
Increase direct sales of medicinal products, 1-4 sq 2017/1-4th quarter 2016 |
Rank in terms of gross turnover per 1-4 sq 2017 |
|
|
1-4 sq 2017 |
1-4 sq 2016 |
||||
|
1 |
Protek |
18.4% |
18.6% |
7.1% |
1 |
|
2 |
Katren |
17.5% |
18.3% |
3.8% |
0.972 |
|
3 |
Pulse |
13.8% |
13.1% |
14.7% |
0.683 |
|
4 |
R-Pharm |
4.8% |
4.8% |
8.7% |
0.266 |
|
5 |
Pharmkomplekt |
4.5% |
3.8% |
28.8% |
0.271 |
|
6 |
BSS |
3.7% |
4.2% |
-4.0% |
0.191 |
|
7 |
FC Grand Capital |
2.7% |
1.8% |
61.8% |
0.153 |
|
8 |
Profitmed |
2.1% |
2.1% |
6.3% |
0.134 |
|
9 |
IRWIN 2 |
1.7% |
1.0% |
93.9% |
0.080 |
|
10 |
Euroservice |
1.3% |
1.4% |
0.8% |
0.081 |
|
Total |
70.5% |
69.2% |
10.8% |
|
|
* compiled based on the data of distributors participating in the ranting
 |
 |
